(Q39583650)

English

Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice

scientific article published on March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

fatty liver disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Xiaoyan Sheng

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Min Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Meng Lu

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Beili Xi

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Hongguang Sheng

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ying Qin Zang

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

300

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

E886-93

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Recent concepts in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

The spectrum of liver disease in the general population: lesson from the Dionysos study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Insulin resistance: a metabolic pathway to chronic liver disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

The protein kinase IKKepsilon regulates energy balance in obese mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Steatohepatitis: a tale of two "hits"?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Anti-cancer properties of anthraquinones from rhubarb

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

LXRs regulate the balance between fat storage and oxidation.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

The role of cytokines and chemokines in the development of steatohepatitis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Nonalcoholic fatty liver disease in the pediatric population

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Diacerhein downregulate proinflammatory cytokines expression and decrease the autoimmune diabetes frequency in nonobese diabetic (NOD) mice.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Nonalcoholic fatty liver disease and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Diacerhein and rhein prevent interleukin-1beta-induced nuclear factor-kappaB activation by inhibiting the degradation of inhibitor kappaB-alpha.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Role of primary intrahepatic T-cell activation in the 'liver tolerance effect'.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Role of LXRs in control of lipogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Putative metabolic effects of the liver X receptor (LXR).

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

The liver as an immunological organ

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00332.2010

21 January 2018

Identifiers

10.1152/AJPENDO.00332.2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39583650&oldid=1842430232"